22 Apr 2015 10:13
Deltex Medical Group said that product delays in its overseas markets and cash difficulties in the NHS weighed on its annual revenue, leading to wider pre-tax losses. The AIM-listed company said its pre-tax loss rose to £3.1m, a 40.9% increase year-on-year, as revenue declined 16.3% to £4.6m, in wha
Read more